Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
Subsai Kongsaengdao,1,2 Narong Maneeton,3 Benchalak Maneeton3 1Division of Neurology, Department of Medicine, Rajavithi Hospital, Department of Medical Services, Public Health Ministry, Bangkok, Thailand; 2Department of Medicine, College of Medicine, Rangsit University, Bangkok, Thailand; 3Departme...
Guardado en:
Autores principales: | Kongsaengdao S, Maneeton N, Maneeton B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be37b59e2ac54cecb927df4822d5b834 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Mark F. Lew, et al.
Publicado: (2021) -
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
por: Kongsaengdao S, et al.
Publicado: (2017) -
Sexual dysfunction in cervical dystonia and blepharospasm
por: Marek M, et al.
Publicado: (2018) -
The dystonia patient a guide to practical management /
Publicado: (2009) -
Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia—A Focus on Tyrosine Hydroxylase Deficiency
por: Gyrid Nygaard, et al.
Publicado: (2021)